Rolitetracycline
- ROLITETRACYCLINE
- 751-97-3
- Reverin
- Syntetrin
- Rolitetraciclina
- Create:2011-12-26
- Modify:2025-01-18
20685-78-3 (mononitrate)
7681-32-5 (nitrate)
- Hydrochloride, Rolitetracycline
- Monohydrochloride, Rolitetracycline
- Mononitrate, Rolitetracycline
- Mononitrate, Sesquihydrate Rolitetracycline
- Nitrate, Rolitetracycline
- Pyrrolidinomethyltetracycline
- Reverin
- Revrin
- Rolitetracycline
- Rolitetracycline Hydrochloride
- Rolitetracycline Monohydrochloride
- Rolitetracycline Mononitrate
- Rolitetracycline Mononitrate, Sesquihydrate
- Rolitetracycline Nitrate
- Sesquihydrate Rolitetracycline Mononitrate
- Tetraverin
- ROLITETRACYCLINE
- 751-97-3
- Reverin
- Syntetrin
- Rolitetraciclina
- Synterin
- Rolitetracyclinum
- Pyrrolidino-methyl-tetracycline
- Velacycline
- N-(Pyrrolidinomethyl)tetracycline
- N-(1-Pyrrolidinylmethyl)-tetracycline
- SQ 15,659
- Bristacin
- CHEBI:63334
- NSC-759177
- Transcycline
- GH9IW85221
- Rolitetracycline (Technical Grade)
- Solvocillin
- (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
- SQ-15659
- 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
- Prm-TC
- Superciclin
- Synotodecin
- Velacicline
- Syntetrex
- Pirrolidinometil-tetraciclina
- (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
- (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-[(pyrrolidin-1-yl)methyl]-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
- DTXSID7023568
- Kinteto
- UNII-GH9IW85221
- Rolitetracyclinum [INN-Latin]
- AAT 4
- Rolitetraciclina [INN-Spanish]
- Tetracycline, pyrrolidinomethyl-
- n-Pyrrolidino-methyl-tetracycline
- Synterin (TN)
- EINECS 212-031-9
- Pirrolidinometil-tetraciclina [Italian]
- Rolitetracycline [USAN:USP:INN:BAN:JAN]
- 68060-64-0
- pyrrolidinylmethyltetracycline
- ROLITETRACYCLINE [MI]
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, (4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
- ROLITETRACYCLINE [INN]
- ROLITETRACYCLINE [JAN]
- SCHEMBL155640
- ROLITETRACYCLINE [USAN]
- CHEMBL1237046
- ROLITETRACYCLINE [MART.]
- SCHEMBL21831095
- GTPL12760
- ROLITETRACYCLINE [WHO-DD]
- IKQRPFTXKQQLJF-IAHYZSEUSA-N
- HMS2094O15
- Pharmakon1600-01505684
- Rolitetracycline (JAN/USAN/INN)
- BCP15881
- Rolitetracycline, analytical standard
- BDBM50477463
- MFCD00056562
- NSC759177
- N-(pyrrolidin-1-ylmethyl)tetracycline
- AKOS024284365
- Tetracycline, N-(pyrrolidinylmethyl)-
- CCG-213512
- DB01301
- NSC 759177
- NCGC00263906-01
- (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
- [(4S,6S,12aS,4aS,5aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1, 11-dioxo(4,5,6,12a,4a,5a-hexahydronaphthacen-2-yl)]-N-(pyrrolidinylmethyl)carb oxamide
- HY-18257
- PD132300
- SO-15659
- SQ 15659
- SBI-0206901.P001
- SO 15,659
- CS-0007350
- D02282
- G12690
- AB01563105_01
- AB01563105_02
- EN300-19651952
- SR-05000001744
- Q3940320
- SR-05000001744-1
- (4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
- (4S,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(pyrrolidin-1-ylmethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
- 2-NAPHTHACENECARBOXAMIDE, 4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-N-(1-PYRROLIDINYLMETHYL)-, (4S-(4.ALPHA.,4A.ALPHA.,5A.ALPHA.,6.BETA.,12A.ALPHA))
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 4 (100%)
Skin Irrit. 2 (100%)
Eye Irrit. 2 (100%)
STOT SE 3 (100%)
IMAP assessments - 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, [4S-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-: Environment tier I assessment
IMAP assessments - 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, [4S-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-: Human health tier I assessment
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=HMEYVGGHISAPJR-IAHYZSEUSA-N
- Australian Industrial Chemicals Introduction Scheme (AICIS)2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-, [4S-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.)]-https://services.industrialchemicals.gov.au/search-assessments/
- ChemIDplusRolitetracycline [USAN:USP:INN:BAN:JAN]https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000751973ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_useRolitetracyclinehttps://www.drugbank.ca/drugs/DB01301
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- EPA DSSToxRolitetracyclinehttps://comptox.epa.gov/dashboard/DTXSID7023568CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeRolitetracycline (EC: 212-031-9)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/38731
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingROLITETRACYCLINEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/GH9IW85221
- ChEBIRolitetracyclinehttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63334
- Open TargetsLICENSEDatasets generated by the Open Targets Platform are freely available for download.https://platform-docs.opentargets.org/licenceROLITETRACYCLINEhttps://platform.opentargets.org/drug/CHEMBL1237046
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jspRolitetracyclinehttps://ctdbase.org/detail.go?type=chem&acc=D012382
- Therapeutic Target Database (TTD)Rolitetracyclinehttps://idrblab.net/ttd/data/drug/details/D05AFR
- Japan Chemical Substance Dictionary (Nikkaji)
- KEGGLICENSEAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial licensehttps://www.kegg.jp/kegg/legal.htmlAnatomical Therapeutic Chemical (ATC) classificationhttp://www.genome.jp/kegg-bin/get_htext?br08303.kegAntiinfectiveshttp://www.genome.jp/kegg-bin/get_htext?br08307.keg
- Metabolomics Workbench
- NCI Thesaurus (NCIt)LICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuseNCI Thesaurushttps://ncit.nci.nih.gov
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/Rolitetracycline
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/Rolitetracyclinehttps://www.whocc.no/atc_ddd_index/?code=J01AA09
- Wikidatarolitetracyclinehttps://www.wikidata.org/wiki/Q3940320
- WikipediaSpiramycinhttps://en.wikipedia.org/wiki/SpiramycinRolitetracyclinehttps://en.wikipedia.org/wiki/Rolitetracycline
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlRolitetracyclinehttps://www.ncbi.nlm.nih.gov/mesh/68012382Anti-Bacterial Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000900
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 403499437https://pubchem.ncbi.nlm.nih.gov/substance/403499437
- NCBI